Difference between revisions of "Moreb J, et al. Cancer Gene Ther. (1996) cited as Ref 665 in DOI: 10.1038/s41392-020-0110-5 (Q9928)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 3, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide (English) | ||
| Property / title: Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:06, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Moreb J, et al. Cancer Gene Ther. (1996) cited as Ref 665 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Moreb J
0 references
Schweder M
0 references
Suresh A
0 references
1996
0 references
Cancer Gene Ther.
0 references
3
0 references
Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide (English)
0 references
